NURS-6630C-9/NURS-6630N-9-Approaches to Treatment2020 Spring

Course NURS-6630C-9/NURS-6630N-9-
Approaches to Treatment2020 Spring I I I I


Test Week I11 IFinal IExam
Status Completed
Attempt 73 I out I of I 75 I points
IS core


Time 1 Ihour, I52 Iminutes Iout Iof I2 Ihours
IElapsed


Results Submitted IAnswers
I

IDisplaye

d
• Question 1 I

0 out Iof I0 Ipoints
When completing this exam, did you comply with Walden University’s Code ofConduct
I I I I I I I I I I I I


including the expectations for academic integrity?
I I I I I I


Selected Ye
Answer: s
• Question 2 I

1 out Iof I1 Ipoints
Parents of a 12-year-old boy want to consider attention deficit
I I I I I I I I I


hyperactivity disorder (ADHD) medication for their son. Which
I I I I I I I I


medication would the PMHNP start?
I I I I I



Selected d.
IA nswer: All of these could potentially treat their son’s symptoms.
I I I I I I I I



• Question 3 I


1 Iout Iof I1 I points
A patient with hypersexual disorder is being assessed for
I I I I I I I I


possible pharmacologic treatment. Why does the PMHNP
I I I I I I I


recommend an antiandrogen for this patient?
I I I I I I




Selected d.
IA nswer: It will block
I I


testosterone
I


.
• Question 4 I

, 1 Iout I of I1 Ipoints
Sandra complains of constipation after being on quetiapine
I I I I I I I I


(SEROQUEL) for several weeks. Constipation is likely caused
I I I I I I I I


by the binding of quetiapine (SEROQUEL) to which receptor?
I I I I I I I I




Selected a.
Answer: M
1
I



• Question 5 I

1 Iout Iof I1 I points
The PMHNP understands that varenicline (CHANTIX) is an
I I I I I I I


effective way to assist patients with smoking cessation. Why is
I I I I I I I I I I


this medication effective for these patients?
I I I I I I




Selected a.
IA nswer: Varenicline is a selective nicotinic acetylcholine receptor I I I I I I


partial agonist
I I



• Question 6 I

1 Iout Iof I1 I points
An 80-year-old female patient diagnosed with Stage II
I I I I I I I


Alzheimer’s has a history of irritable bowel syndrome. Which
I I I I I I I I I


cholinergic drug may be the top choice for treatment given the
I I I I I I I I I I I


patient’s gastrointestinal problems?
I I I




Selected b.
IA nswer: Donepezil
I


(Aricept)
I



• Question 7 I


1 Iout Iof I1 I points
Molly is a 52-year-old female that has a diagnosis of
I I I I I I I I I


fibromyalgia. She complains of fatigue and cognitive
I I I I I I I


difficulties. Which medication is the PMHNP most likely to
I I I I I I I I


prescribe?
I




Selected b.
IA nswer: Milnacipran
I


(SAVELLA)
I

, • Question 8 I


1 Iout Iof I1 I points
A 71-year-old male patient comes to an appointment with his
I I I I I I I I I


65-year-old wife. They are both having concerns related to her
I I I I I I I I I I


memory and ability to recognize faces. The PMNHP is
I I I I I I I I I


considering prescribing memantine (Namenda) based on the
I I I I I I I


following symptoms:
I I




Selected a.
IA nswer: Amnesia, apraxia, I


agnosia
I



• Question 9 I

1 Iout Iof I1 I points
A PMHNP supervisor is discussing with a nursing student how
I I I I I I I I I


stimulants and noradrenergic agents assist with ADHD
I I I I I I I


symptoms. What is the appropriate response?
I I I I I I



Selected c.
IA nswer: All of these areI I I


correct
I



• Question 10 I


1 Iout Iof I1 I points
The PMHNP is attempting to treat a patient’s chronic
I I I I I I I I


insomnia and wishes to start with an initial prescription that
I I I I I I I I I


has a half-life of approximately 1–2 hours. What is the most
I I I I I I I I I I I


appropriate prescription for the PMHNP to make?
I I I I I I I




Selected c.
IA nswer: Triazolam
I


(Halcion)
I



• Question 11 I

1 Iout Iof I1 I points
The novel neurotransmitter adenosine is responsible for the
I I I I I I I


sleep-wake cycle by increasing throughout the day and
I I I I I I I I


diminishing during night. Which of the follow is an antagonist of
I I I I I I I I I I I


adenosine?
I




Selected d.